PSTM Abstract Supplement
INTRODUCTION:
In today's healthcare market, patients have high levels of access to information and choice. As a profession, plastic surgeons must meet the public demand for aesthetic and reconstructive procedures. Patients often search for physicians using Google, the world's most popular search engine. Google offers insights into patient needs through their search history.
METHODS:
The Google Trends data, which reveal Relative Search Volumes (RSV), were pulled for all searches for "plastic surgery" from the June 2014-June 2015 periods.
The RSV data are normalized using the total search volume per region. The number of active plastic surgeons per state, provided by the American Society of Plastic Surgeons (ASPS), was divided by the US Census Bureau population estimates for 2014 to achieve a surgeons-per-capita value for each state, or "surgical concentration." The Google score was divided by this surgical concentration to yield a "surgical demand index" for each of the fifty states. Median two-family incomes were obtained from the Census Bureau.
RESULTS:
Florida, New York, and Connecticut had the greatest surgical concentration of ASPS surgeons per ten thousand people (0.220, 0.217, and 0.209, respectively) , and Wyoming, Arkansas, and Vermont had the smallest concentration (0.051, 0.071, 0.080). California exhibited the greatest number of Google searches (RSV=100), followed by Florida and Hawaii (RSV=95). Oregon (RSV=38), Virginia (RSV=52), and Alaska (RSV=58) had the lowest number of relative searches. The "surgical demand index" was greatest in Wyoming (1187.778) [2] [3] [4] [5] On occasion, atypical proliferative lesion of variable malignancy potential is also reported, which may become an area of concern given the management of such lesions may be unfamiliar to plastic surgeons. We aimed to provide a review of commonly diagnosed proliferative lesions identified in routine reduction mammoplasty specimens and the best supporting evidence for their subsequent management.
METHODS:
Retrospective literature review using a PubMed search of all English-language articles published between 1990 and 2016 containing the phrases ("reduction mammoplasty", "breast reduction", "proliferative", "atypical", "hyperplasia", "ductal", "epithelial", "lobular", "stromal" and "meshchymal") was completed. A total of 210 publications were generated after initial screening with 10 articles ultimately incorporated after comprehensive review.
RESULTS:
Commonly encountered proliferative lesions among reduction mammoplasty specimens include pseudoangiomatous stromal hyperplasia (PASH), atypical lobular hyperplasia (ALH), atypical ductal hyperplasia (ADH) and flat epithelial atypia (FEA). PASH and FEA with no concomitant atypical ductal or lobular lesions confers no risk of subsequent malignancy and routine standard of care is recommended. ADH and ALH confer a four-fivefold increased risk of subsequent breast carcinoma with increased risk among high risk individuals. 2 For this patient cohort, current management strategies recommend referral to a breast program, biannual clinical exam, yearly mammography with breast MRI, genetic testing for BRCA 1/2 gene mutation with or without chemoprevention in higher risk individuals.
CONCLUSION:
Our review provides important findings by highlighting the most frequently encountered atypical proliferative lesions among routine reduction mammoplasty specimens as well as current evidence supporting management strategies.
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